SCHEMBL459100

SCHEMBL459100

CCC1CNCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2919395 0.86
SCHEMBL789308 0.82
SCHEMBL789435 0.80 NOS1 (0.35)
SCHEMBL2918213 0.79
SCHEMBL254648 0.79 GBA1 (0.33)
SCHEMBL3254586 0.77 ALDH1A1 (0.36)
SCHEMBL1461367 0.77 CYP2D6 (0.36)
SCHEMBL1233220 0.76
SCHEMBL948954 0.76
SCHEMBL2917920 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 722 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107955-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER ONCONOVA THERAPEUTICS, INC. (US) 2024-05-23 WO claimed
US-20240051975-A1 NOVEL NAMPT ENZYME AGONIST AND PREPARATION AND USE THEREOF TSINGHUA UNIVERSITY (CN) 2024-02-15 US claimed
WO-2023230288-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER ONCONOVA THERAPEUTICS, INC. (US) 2023-11-30 WO claimed
CN-117088895-A Scutellarin compound and preparation method and application thereof 福建医科大学 2023-11-21 CN claimed
WO-2023081400-A9 DIRECTED DEGRON MOLECULES AND APPLICATIONS THEREOF THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) 2023-06-01 WO claimed
WO-2023081400-A1 DIRECTED DEGRON MOLECULES AND APPLICATIONS THEREOF THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) 2023-05-11 WO claimed
CN-114805438-A Phosphoacyl-containing TYK2 inhibitor compounds 正大天晴药业集团股份有限公司 2022-07-29 CN claimed
CN-114716343-A Novel NAMPT enzyme agonist, preparation and application thereof 清华大学 2022-07-08 CN claimed
US-20220128562-A1 BIOMARKERS PREDICTIVE OF CANCER CELL RESPONSE TO ML329 OR A DERIVATIVE THEREOF UNIVERSITY OF KANSAS 2022-04-28 US claimed
CN-110475777-B Novel pyrido [2,3-b ] indole compounds for the treatment and prevention of bacterial infections 豪夫迈·罗氏有限公司 2022-04-15 CN claimed
EP-0448774-A2 Triazinic compounds MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) 1991-10-02 EP claimed
EP-0425283-A2 Novel triazolyl hydrazide derivatives and process for their preparation EGIS GYOGYSZERGYAR (HU) 1991-05-02 EP claimed
EP-0415371-A2 Self-extinguishing polymeric compositions MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) 1991-03-06 EP claimed
EP-0406810-A1 Self-extinguishing polymeric compositions MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) 1991-01-09 EP claimed
EP-0201400-B1 4-PHENYL PROPYL INDOLE DERIVATIVES AND THEIR SALTS, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1989-07-19 EP claimed
US-4808609-A Amino-(hydroxy)alkoxy-4-phenylpropyl indoles having antiarrythmic activity ROUSSEL UCLAF (FR) 1989-02-28 US claimed
US-4791109-A Novel indole carboxamides ROUSSEL UCLAF (FR) 1988-12-13 US claimed
EP-0142467-B1 POLYMER COMPOUNDS CONTAINING PIPERIDYL GROUPS AND THEIR USE AS STABILISERS IN SYNTHETIC POLYMERS CIBA-GEIGY S.p.A. (IT) 1988-08-24 EP claimed
EP-0150139-B1 INDOLE-ETHYLPHENOL DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR PEPARATION, THEIR USES AS MEDICINES AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1988-05-18 EP claimed
US-4650811-A HYPOTENSIVE ROUSSEL UCLAF (FR) 1987-03-17 US claimed